首页> 美国卫生研究院文献>World Journal of Gastroenterology >DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV
【2h】

DNA immunization with fusion genes encoding different regions of hepatitis C virus E2 fused to the gene for hepatitis B surface antigen elicits immune responses to both HCV and HBV

机译:用编码与丙型肝炎表面抗原基因融合的丙型肝炎病毒E2不同区域的融合基因进行DNA免疫可引起对HCV和HBV的免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: Both Hepatitis B virus (HBV) and Hepatitis C virus (HCV) are major causative agents of transfusion-associated and community-acquired hepatitis worldwide. Development of a HCV vaccine as well as more effective HBV vaccines is an urgent task. DNA immunization provides a promising approach to elicit protective humoral and cellular immune responses against viral infection. The aim of this study is to achieve immune responses against both HCV and HBV by DNA immunization with fusion constructs comprising various HCV E2 gene fragments fused to HBsAg gene of HBV.METHODS: C57BL/6 mice were immunized with plasmid DNA expressing five fragments of HCV E2 fused to the gene for HBsAg respectively. After one primary and one boosting immunizations, antibodies against HCV E2 and HBsAg were tested and subtyped in ELISA. Splenic cytokine expression of IFN-γ and IL-10 was analyzed using an RT-PCR assay. Post-immune mouse antisera also were tested for their ability to capture HCV viruses in the serum of a hepatitis C patient in vitro.RESULTS: After immunization, antibodies against both HBsAg and HCV E2 were detected in mouse sera, with IgG2a being the dominant immunoglobulin sub-class. High-level expression of INF-γ was detected in cultured splenic cells. Mouse antisera against three of the five fusion constructs were able to capture HCV viruses in an in vitro assay.CONCLUSION: The results indicate that these fusion constructs could efficiently elicit humoral and Th1 dominant cellular immune responses against both HBV S and HCV E2 antigens in DNA-immunized mice. They thus could serve as candidates for a bivalent vaccine against HBV and HCV infection. In addition, the capacity of mouse antisera against three of the five fusion constructs to capture HCV viruses in vitro suggested that neutralizing epitopes may be present in other regions of E2 besides the hypervariable region 1.
机译:目的:乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)都是世界范围内与输血相关和社区获得性肝炎的主要病原体。开发HCV疫苗以及更有效的HBV疫苗是当务之急。 DNA免疫为引发针对病毒感染的保护性体液和细胞免疫应答提供了一种有前途的方法。这项研究的目的是通过用包含与HBV HBsAg基因融合的各种HCV E2基因片段的融合构建体进行DNA免疫来实现针对HCV和HBV的免疫反应。方法:用表达HCV五个片段的质粒DNA免疫C57BL / 6小鼠E2分别与HBsAg基因融合。一次和一次加强免疫后,针对HCV E2和HBsAg的抗体进行了测试,并在ELISA中进行了亚型化。使用RT-PCR测定法分析了IFN-γ和IL-10的脾细胞因子表达。还测试了免疫后小鼠抗血清在体外捕获丙型肝炎患者血清中HCV病毒的能力。结果:免疫后,在小鼠血清中检测到针对HBsAg和HCV E2的抗体,其中IgG2a是主要的免疫球蛋白。子类。在培养的脾细胞中检测到INF-γ的高表达。结论:结果表明,这些融合构建体可以有效地引起针对DNA中的HBV S和HCV E2抗原的体液和Th1显性细胞免疫应答,而针对这五个融合构建体中的三个的小鼠抗血清能够在体外检测中捕获HCV病毒。 -免疫的小鼠。因此,它们可以作为抗HBV和HCV感染的二价疫苗的候选药物。此外,小鼠抗血清针对五种融合构建物中的三种的体外捕获HCV病毒的能力表明,中和性表位可能会在高变区1之外的E2其他区域中出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号